Psychopharmacological treatment of mentally retarded adults with depressive disorders;WIE WERDEN GEISTIG BEHINDERTE ERWACHSENE MIT DEPRESSIVEN STORUNGEN PSYCHOPHARMAKOLOGISCH BEHANDELT?

Nervenarzt

Volumn 67, Issue 3, 1996, Pages 216-218

  Meins, W ^a  

^a ALBERTINEN KRANKENHAUS   (Germany)

Author keywords

depressive disorders; DSM III R; mental retardation; psychopharmacological treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; SULPIRIDE; TRANQUILIZER; TRIMIPRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; RESIDENTIAL CARE;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GERMANY; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; PSYCHOTROPIC DRUGS; RESIDENTIAL FACILITIES;

EID: 0029866636     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aman MG, Field CJ, Bridgman GD (1985) City-wide survey of drug patterns among institutionalized retarded persons. Appl Res Ment Retard 5: 159-171
2. Aman MG, Singh NN (1991) Pharmacological intervention. In: Matson JL, Mulick JA (eds) Handbook of mental retardation. Pergamon, New York, pp 347-372
3. American Psychiatric Association (1989) Diagnostisches und Statistisches Manual Psychischer Storungen. DSM-III-R. Deutsche Bearbeitung. Beltz, Weinheim
4. Benkert O, Hippius H (1992) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New York
5. Brugha TS, Bebbington PE (1992) The undertreatment of depression. Eur Arch Psychiatry Clin Neurosci 242: 103-108
6. Corrigan PW, Yudofsky SC, Silver JM (1993) Pharmacological and behavioral treatments for aggressive psychiatric inpatients Hosp Community Psychiatry 44: 125-133
7. Dosen A, Menolascino FJ (eds) Depression in mentally retarded children and adults. Logon, Leiden, NL
8. Hennicke K, Rotthaus W (Hrsg) (1993) Psychotherapie und geistige Behinderung. Verlag Modernes Lernen, Dortmund
9. Hill BK, Balow EA, Bruininks RH (1985) A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people Psychopharmacol Bull 21: 279-284
10. Howland RH (1992) Fluoxetine treatment of depression in mentally retarded adults. J Nerv Ment Dis 180: 202-205
11. Intagliata J, Rinck C (1985) Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacol Bull 21: 268-278
12. Kovacs M (1985) The Children's Depression Inventory. Psychopharmacol Bull 21: 995-998
13. Linaker OM (1990) Frequency and determinants for psychotropic drug use in an institution for the mentally retarded. Br J Psychiatry 156: 525-530
14. Lotz W, Koch U, Stahl B (Hrsg) (1994) Psychotherapeutische Behandlung geistig behinderter Menschen. Huber, Bern
15. Martin JE, Agran M (1985) Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements. Appl Res Ment Retard 6: 33-49
16. Meins W (1991) Aktuelle Entwicklungen in der Psychopharmakotherapie von Personen mit geistiger Behinderung. Krankenhauspsychiatrie 2: 109-114
17. Meins W (1993) Assessment of depression in mentally retarded adults: reliability and validity of the Children's Depression Inventory (CDI). Res Dev Disabil 14: 299-312
18. Meins W (1995) Symptoms of major depression in mentally retarded adults. J Intellect Disabil Res 39: 41-45
19. Meins W, Auwetter J, Krausz M, Turnier Y (1993) Behandlung mit Psychopharmaka in unterschiedlichen Einrichtungen für geistig Behinderte. Nervenarzt 64: 451-455
20. Schmauß M (1993) Antidepressivabehandlung depressiver Erkrankungen. In: Möller H-J (Hrsg) Therapie psychiatrischer Erkrankungen. Enke, Stuttgart, S 277-287
21. Sovner R (1989) Treating mentally retarded adults with psychotropic drugs: a clinical perspective. In: Fletcher R, Menolascino FJ (eds) Mental retardation and mental illness. Lexington Books, Lexington, pp 157-183